Watching ASLAN Pharmaceuticals; Piper Sandler Out With Note Saying "Co Believes That A Partner Or Acquirer Will See The Value And Differentiation Of Once Monthly Subcutaneous Eblasakimab Vs. Every Other Week Dupixent"
Author: Benzinga Newsdesk | March 11, 2024 02:45pm